Circulating C-peptide immunoreactivity. Studies in normals and diabetic patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001798:Blood Proteins; D002648:Child; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood; D000939:Epitopes; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood*; D007330:Insulin Antibodies; D007336:Insulin, Isophane / Q000627:therapeutic use; D007457:Iodine Radioisotopes; D007515:Islets of Langerhans / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000097:blood* / Q000302:isolation & purification; D011384:Proinsulin / Q000097:blood*; D011485:Protein Binding; D011863:Radioimmunoassay
D001798:Blood Proteins; D000939:Epitopes; D007328:Insulin; D007330:Insulin Antibodies; D007457:Iodine Radioisotopes; D010455:Peptides; D007336:Insulin, Isophane; D011384:Proinsulin